Macromolecular assemblage in the design of a synthetic AIDS vaccine.
about
Synthesis and application of peptide dendrimers as protein mimetics.Novel dendrimer based polyurethanes for PEO incorporation.A Melanophore-Based Screening Assay for Erythropoietin Receptors.Peptide vaccines and peptide libraries.TLR1/2 activation during heterologous prime-boost vaccination (DNA-MVA) enhances CD8+ T Cell responses providing protection against Leishmania (Viannia)Defined synthetic vaccines.Role of attached lipid in immunogenicity of Borrelia burgdorferi OspAA potential peptide vaccine against two different strains of influenza virus isolated at intervals of about 10 years.Current status of multiple antigen-presenting peptide vaccine systems: Application of organic and inorganic nanoparticles.Dendrimer-based nanocarriers: a versatile platform for drug delivery.Covalent bond or noncovalent bond: a supramolecular strategy for the construction of chemically synthesized vaccines.Delivery of protein antigen to the major histocompatibility complex class I-restricted antigen presentation pathway.Biosynthetic lipid-tagging of antibodies.Anti-hepatitis A virus antibody response elicited in mice by different forms of a synthetic VP1 peptide.The adsorption-desorption transition of double-stranded DNA interacting with an oppositely charged dendrimer induced by multivalent anions.Anti-MUC1 class I restricted CTLs in metastatic breast cancer patients immunized with a synthetic MUC1 peptide.Synthetic carbohydrate-based vaccines: synthesis of an L-glycero-D-manno-heptose antigen–T-epitope–lipopeptide conjugate
P2860
Q30368977-0BD7C087-10F7-4F08-920D-398381B3E0D8Q30714203-C11B45C3-E30C-4A7E-929F-05AB12EA03DEQ30875166-A448219B-0F9E-48FD-99F1-B7E2990A6CF3Q30992372-7002F8CD-74D3-418E-A95F-84AE1138BAE1Q33939303-6FDDF324-A231-449E-A3FA-267D81944E0FQ34280941-FB99F0F1-541F-458A-8FC5-7DE4AE02CE0FQ34520778-DE2E4687-D873-4A27-AE13-4902FA2D414DQ35799165-A79FC857-B47E-40BD-9C78-C45ADCC48C94Q37921384-9956E15E-3931-4BC0-A102-997CE28D9AE8Q38820422-CD6E1AE1-23F6-4B59-914B-6439F017E371Q38962995-00B1FD84-E39B-4961-A750-9C82525D1FAEQ40381395-B563379F-084F-4389-A05A-DDC43B946AFCQ40764061-F22BD75E-3604-496D-9DF5-504D1FD898B0Q45771956-BD9D8E05-F164-4135-B1BA-F221F57F8CF9Q45865562-92BFF7DA-DE6D-4FEF-8F0E-E75591EC3AD0Q47975807-00BC5C85-BDEA-4C98-A44E-3F780261118DQ57242626-2E8BECBE-EB5E-451D-B04F-98D4DE15E03E
P2860
Macromolecular assemblage in the design of a synthetic AIDS vaccine.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 1992
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Macromolecular assemblage in the design of a synthetic AIDS vaccine.
@en
Macromolecular assemblage in the design of a synthetic AIDS vaccine.
@nl
type
label
Macromolecular assemblage in the design of a synthetic AIDS vaccine.
@en
Macromolecular assemblage in the design of a synthetic AIDS vaccine.
@nl
prefLabel
Macromolecular assemblage in the design of a synthetic AIDS vaccine.
@en
Macromolecular assemblage in the design of a synthetic AIDS vaccine.
@nl
P2093
P2860
P356
P1476
Macromolecular assemblage in the design of a synthetic AIDS vaccine.
@en
P2093
P2860
P304
P356
10.1073/PNAS.89.9.3879
P407
P577
1992-05-01T00:00:00Z